Switching patients with inflammatory arthritis from Etanercept (Enbrel<sup>®</sup>) to the biosimilar drug, SB4 (Benepali<sup>®</sup>): A single-centre retrospective observational study in the UK and a review of the literature
Mediterranean Journal of Rheumatology